反応 #626213

ord-85d3a62cbb0b476ca8957105d21161bb

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    濃縮The reaction was concentrated in vacuo
  2. 2
    その他the material purified by reverse preparative HPLC
  3. 3
    その他to yield the crude product
  4. 4
    workup.STIRRINGthe mixture stirred at ambient temperature for 2 hours
  5. 5
    濃縮The mixture was concentrated in vacuo
  6. 6
    その他was purified by reverse preparative HPLC

実験手順

To (S)-1-(2-hydroxyethyl)-4-isopropyl-3-(3-(4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazol-3-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)imidazolidin-2-one (0.18 g, 0.32 mmol) was added trifluoroacetic acid (5 mL) and the reaction was stirred at ambient temperature for 3 hours. The reaction was concentrated in vacuo and the material purified by reverse preparative HPLC to yield the crude product and the corresponding trifluoroacetate ester. To this material was added 1N NaOH/MeOH and the mixture stirred at ambient temperature for 2 hours. The mixture was concentrated in vacuo. The combined crude product was purified by reverse preparative HPLC to give (S)-3-(3-(4-(1H-1,2,4-triazol-3-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)-1-(2-hydroxyethyl)-4-isopropylimidazolidin-2-one (0.0061 g, 0.014 mmol, 4.4% yield) as the mono TFA salt. LCMS (APCI+) m/z 433 [M+H]+.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US08865726B2uspto-grants-2014_10